128 related articles for article (PubMed ID: 9227843)
1. Effect of intrathecal pretreatment with the neurokinin receptor antagonist CP-99994 on the expression of naloxone-precipitated morphine withdrawal symptoms.
Buccafusco JJ; Shuster LC
Brain Res Bull; 1997; 43(3):321-6. PubMed ID: 9227843
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular and behavioural effects induced by naloxone-precipitated morphine withdrawal in rat: characterization with tachykinin antagonists.
Michaud N; Couture R
Neuropeptides; 2003 Dec; 37(6):345-54. PubMed ID: 14698677
[TBL] [Abstract][Full Text] [Related]
3. Spinal NMDA receptor--nitric oxide mediation of the expression of morphine withdrawal symptoms in the rat.
Buccafusco JJ; Terry AV; Shuster L
Brain Res; 1995 May; 679(2):189-99. PubMed ID: 7633880
[TBL] [Abstract][Full Text] [Related]
4. Participation of different brain regions in the anti-narcotic withdrawal action of clonidine in the dependent rat.
Buccafusco JJ
Brain Res; 1990 Apr; 513(1):8-14. PubMed ID: 2350687
[TBL] [Abstract][Full Text] [Related]
5. Spinal cholinergic neurons and the expression of morphine withdrawal symptoms in the rat.
Marshall DC; Buccafusco JJ
J Neurosci; 1987 Mar; 7(3):621-8. PubMed ID: 3559705
[TBL] [Abstract][Full Text] [Related]
6. Role of spinal and supraspinal muscarinic receptors in the expression of morphine withdrawal symptoms in the rat.
Holland LN; Shuster LC; Buccafusco JJ
Neuropharmacology; 1993 Dec; 32(12):1387-95. PubMed ID: 8152529
[TBL] [Abstract][Full Text] [Related]
7. Supraspinal and spinal mediation of naloxone-induced morphine withdrawal in rats.
Marshall DC; Buccafusco JJ
Brain Res; 1985 Mar; 329(1-2):131-42. PubMed ID: 4038893
[TBL] [Abstract][Full Text] [Related]
8. RP 67580, a selective antagonist of neurokinin-1 receptors, modifies some of the naloxone-precipitated morphine withdrawal signs in rats.
Maldonado R; Girdlestone D; Roques BP
Neurosci Lett; 1993 Jun; 156(1-2):135-40. PubMed ID: 7692360
[TBL] [Abstract][Full Text] [Related]
9. Substance P-(1-7), a substance P metabolite, inhibits withdrawal jumping in morphine-dependent mice.
Kreeger JS; Larson AA
Eur J Pharmacol; 1993 Jul; 238(1):111-5. PubMed ID: 7691618
[TBL] [Abstract][Full Text] [Related]
10. [Activation of the spinal extracellular signal-regulated kinase is involved in morphine dependence and naloxone-precipitated withdrawal response].
He JH; Cao JL; Xu YB; Song XS; Ding HL; Zeng YM
Sheng Li Xue Bao; 2005 Oct; 57(5):557-65. PubMed ID: 16220193
[TBL] [Abstract][Full Text] [Related]
11. [Different roles of the spinal protein kinase C alpha and gamma in morphine dependence and naloxone-precipitated withdrawal].
Cao JL; Ding HL; He JH; Zhang LC; Wang JK; Zeng YM
Sheng Li Xue Bao; 2005 Apr; 57(2):161-8. PubMed ID: 15830100
[TBL] [Abstract][Full Text] [Related]
12. Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence.
Liu J; Schulteis G
Pharmacol Biochem Behav; 2004 Sep; 79(1):101-8. PubMed ID: 15388289
[TBL] [Abstract][Full Text] [Related]
13. [The different roles of the spinal protein nNOS and iNOS in morphine naloxone-precipitated withdrawal response].
Liu HL; Qian YN
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2012 May; 28(3):249-53. PubMed ID: 22860427
[TBL] [Abstract][Full Text] [Related]
14. Suppression of naloxone-precipitated withdrawal jumps in morphine-dependent mice by stimulation of prostaglandin EP3 receptor.
Nakagawa T; Minami M; Katsumata S; Ienaga Y; Satoh M
Br J Pharmacol; 1995 Nov; 116(6):2661-6. PubMed ID: 8590986
[TBL] [Abstract][Full Text] [Related]
15. Role of beta-adrenoceptors in the expression of morphine withdrawal signs.
Funada M; Suzuki T; Sugano Y; Tsubai M; Misawa M; Ueda H; Misu Y
Life Sci; 1994; 54(8):PL113-8. PubMed ID: 7509021
[TBL] [Abstract][Full Text] [Related]
16. Resting and evoked spinal substance P release during chronic intrathecal morphine infusion: parallels with tolerance and dependence.
Gu G; Kondo I; Hua XY; Yaksh TL
J Pharmacol Exp Ther; 2005 Sep; 314(3):1362-9. PubMed ID: 15908510
[TBL] [Abstract][Full Text] [Related]
17. Spinal amino acid release and precipitated withdrawal in rats chronically infused with spinal morphine.
Jhamandas KH; Marsala M; Ibuki T; Yaksh TL
J Neurosci; 1996 Apr; 16(8):2758-66. PubMed ID: 8786451
[TBL] [Abstract][Full Text] [Related]
18. Orexin type 1 receptor antagonism in Lateral Paragigantocellularis nucleus attenuates naloxone precipitated morphine withdrawal symptoms in rats.
Ahmadi-Soleimani SM; Ghaemi-Jandabi M; Azizi H; Semnanian S
Neurosci Lett; 2014 Jan; 558():62-6. PubMed ID: 24211689
[TBL] [Abstract][Full Text] [Related]
19. Withdrawal from acute morphine dependence is accompanied by increased anxiety-like behavior in the elevated plus maze.
Zhang Z; Schulteis G
Pharmacol Biochem Behav; 2008 May; 89(3):392-403. PubMed ID: 18308382
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide synthase inhibitors attenuate acute and chronic morphine withdrawal response in the rat locus coeruleus: an in vivo voltammetric study.
Hall S; Milne B; Jhamandas K
Brain Res; 1996 Nov; 739(1-2):182-91. PubMed ID: 8955938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
